Carolien H. M. van Deurzen

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• APOBEC3B protein expression associates with poor prognosis for breast cancer patients with ER-positive disease

  Breast Cancer Research · 2025-12-09 · 3 citations

• HER2-low breast cancer in routine practice: a nationwide study of diagnostic variability across pathology laboratories

  Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2025-09-16 · 2 citations

• Motion based ex vivo (MOTEX) culture of breast tumor slices sustains microenvironment composition

  Neoplasia · 2025-08-21

• Decision‐making in breast pathology reporting: the effect of clinical relevant thresholds

  Histopathology · 2025-08-05

• Predictive Histopathological Markers for Upstaging to Invasive Carcinoma after a Biopsy Diagnosis of Ductal Carcinoma in situ of the Breast: A Hypothesis-Generating Systematic Review

  Pathobiology · 2025-07-26

• Clinicopathological and molecular characterization of inflammatory breast cancer, the prospective INFLAME registry study

  npj Breast Cancer · 2025-05-29 · 4 citations

• Reproducibility of Equivocal HER2 In Situ Hybridization Groups 3 and 4, and Comparison With HER2 mRNA Expression: The Thin Line Between Amplified and Nonamplified Breast Cancers

  Archives of Pathology & Laboratory Medicine · 2025-04-28

• HER2-low across solid tumours: different incidences and definitions

  Pathology · 2025-03-19 · 4 citations

• High-impact complications after breast cancer surgery in the Dutch national quality registry: evaluating case-mix adjustment for hospital comparisons

  BJS Open · 2024-12-30 · 4 citations

• Supplementary fig 1 from Ovarian Cancer–Specific <i>BRCA</i>-like Copy-Number Aberration Classifiers Detect Mutations Associated with Homologous Recombination Deficiency in the AGO-TR1 TrialPreprint

  2024-11-25

• Supplementary fig 3 from Ovarian Cancer–Specific <i>BRCA</i>-like Copy-Number Aberration Classifiers Detect Mutations Associated with Homologous Recombination Deficiency in the AGO-TR1 TrialPreprint

  2024-11-25

• Supplementary fig 2 from Ovarian Cancer–Specific <i>BRCA</i>-like Copy-Number Aberration Classifiers Detect Mutations Associated with Homologous Recombination Deficiency in the AGO-TR1 TrialPreprint

  2024-11-25

• Supplementary Data from Ovarian Cancer–Specific <i>BRCA</i>-like Copy-Number Aberration Classifiers Detect Mutations Associated with Homologous Recombination Deficiency in the AGO-TR1 TrialPreprint

  2024-11-25

• Supplementary fig 4 from Ovarian Cancer–Specific <i>BRCA</i>-like Copy-Number Aberration Classifiers Detect Mutations Associated with Homologous Recombination Deficiency in the AGO-TR1 TrialPreprint

  2024-11-25

• Data from Ovarian Cancer–Specific <i>BRCA</i>-like Copy-Number Aberration Classifiers Detect Mutations Associated with Homologous Recombination Deficiency in the AGO-TR1 TrialPreprint

  2024-11-25

• A Comparison Between Immunohistochemistry and mRNA Expression to Identify Human Epidermal Growth Factor Receptor 2–Low Breast Cancer

  Archives of Pathology & Laboratory Medicine · 2024-10-29 · 6 citations

• Systematic assessment of HER2 status in ductal carcinoma in situ of the breast: a perspective on the potential clinical relevance

  Breast Cancer Research · 2024-08-27 · 10 citations

• Spatially-resolved tumour infiltrating immune cells and prognosis in breast cancerPreprint

  medRxiv · 2024-07-22